Sign in
8-K

Current Report

Atara Biotherapeutics, Inc. Filed Acc 0001193125-25-232117

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading d802811d8k.htm…